Fact CheckerSign in

NCT07399262Recruiting

Music-Augmented Rhythmic Gait Training in Multiple Sclerosis

Music-Augmented Versus Non-Music Technology-Based Rhythmic Gait Training in Multiple Sclerosis: A Randomized Controlled Trial of Gait Performance and Clinical Outcomes

Source: ClinicalTrials.gov · Last updated 10 Feb 2026

Brief summary (registry, in English)

This randomized controlled trial aims to compare the effects of technology-based rhythmic gait training performed with and without music on walking performance and clinical outcomes in individuals with multiple sclerosis (MS). Thirty-two participants with mild to moderate disability will be randomly assigned to either a music-assisted rhythmic gait training group or a non-music control group, with both interventions delivered via telerehabilitation. Outcomes related to gait performance, balance, fatigue, and cognitive function will be assessed before and after a four-week intervention period.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
32 (estimated)
First submitted
29 Jan 2026
Start date
Jan 2026
Primary completion date
Jun 2026
Lead sponsor
Biruni University
NCT number
NCT07399262

What you commit to

  • Study type: Interventional
  • Planned participants: 32
  • From Jan 2026 to the primary completion date, Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Presence of hearing or visual impairments
    • Current participation in any structured exercise program
    • Presence of other neurological, cardiovascular, or orthopedic disorders
    • History of MS relapse or change in disease-modifying treatment within the last 6 months
    • Physical conditions preventing safe participation in the exercise program
    • Comorbid conditions that adversely affect oxygen transport (e.g., severe anemia, peripheral arterial disease)

Who the study is looking for

  • Expanded Disability Status Scale (EDSS) score between 0 and 4.0
    • Access to the internet via a high-speed smartphone or computer
    • A score of at least 21 on the Montreal Cognitive Assessment (MoCA)
    • Functional Ambulation Scale score of Stage 3 or higher

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Biruni University
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.